PDK1 deficiency blocks proliferation of colon cancer cells and leads to apoptosis while altering actin polymerization, reducing cell migration, and enhancing the sensitivity of tumor cells to chemotherapy and radiotherapy (Lu et al., 2010). Here, PDK1 is linked to colonic neoplasm.